2. UroToday Home
  3. Video Lectures

Localized Prostate Cancer Videos

Treatment-Specific Out-of-Pocket Costs for Patients Undergoing Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Differences in Mental Health Outcomes According to the Treatment Received for Men Being Treated with Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Using MRI to Safely Prevent Unnecessary Protocol-Advised Repeat Biopsy During Active Surveillance Journal Club - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
Comparing the Relative Benefits of Radiotherapy Dose Escalation ± Short-Term or Long-Term ADT as Treatment Intensification for Localized Prostate Cancer Journal Club - - Christopher Wallis & Zachary Klaassen
January 5, 2023
Details
10-year Results DART 01-05, High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 15, 2022
Details
The Molecular Biology of Prostate Cancer - Christopher Barbieri
October 28, 2022
Details
DNA Repair Genes Associated With Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
September 29, 2022
Details
The Role of Imaging Before and After Diagnosis of Localized Prostate Cancer - Masoom Haider
September 15, 2022
Details
Deciding Against Active Surveillance: How Genomic Testing Impacted Treatment Decision-Making Among a Predominantly African American Population - Peter Gann and Adam Murphy
August 3, 2022
Details
How Genomic Testing Impacts NCCN Risk Classification of Black Men with Low and Intermediate Risk Prostate Cancer - Andrew Winer
August 2, 2022
Details
The ENACT Trial: Ezalutamide Monotherapy plus Active Surveillance vs Active Surveillance Alone in Patients with Low-Risk or Intermediate-Risk Prostate Cancer - Neal Shore
July 27, 2022
Details
LuTectomy, a Single-Arm Study of the Dosimetry, Safety, and Potential Benefit of 177Lu-PSMA-617 Prior to Radical Prostatectomy - Declan Murphy & Renu Eapen
July 5, 2022
Details
Incorporating Genomic Testing for Prostate Cancer into Your Practice - Daniel Lin
June 24, 2022
Details
Genomic Risk Classification in Localized Prostate Cancer - Matthew Cooperberg
June 20, 2022
Details
Prostate Volume, Baseline Urinary Symptoms, and Their Association with Treatment Choice and Post-Treatment Urinary Function in Men with Localized Prostate Cancer, The CEASAR Study - Daniel Barocas
June 2, 2022
Details
Barriers and Opportunities in Active Surveillance, HIFU, and Focal Therapy in Latin American Countries - Laurence Klotz
May 23, 2022
Details
Active Surveillance for Patients With Intermediate-Risk Prostate Cancer - Stacy Loeb
May 15, 2022
Details
Novel Approaches in the Management of High-Risk Prostate Cancer - Ray Manneh Kopp
May 11, 2022
Details
The Benefit of ADT Treatment Intensification with Radiotherapy for Men with Localized Prostate Cancer, Journal Club - Christopher Wallis & Zachary Klaassen
May 10, 2022
Details
Treatment Delay Experiences Among Black and White Men with Prostate Cancer - Bhav Jain
April 24, 2022
Details
Risk Stratification for Localized Prostate Cancer - Matthew Cooperberg
March 29, 2022
Details
Associations of Adverse Pathology With 20 Year Risk of Distant Metastasis and Prostate Cancer Specific Mortality - Michael Brooks
March 16, 2022
Details
Validating the Association of Adverse Pathology with Distant Metastasis and Prostate Cancer Mortality 20-Years After Radical Prostatectomy - Eric Klein
March 10, 2022
Details
AI-Derived Digital Pathology-Based Biomarker To Predict the Benefit of ADT in Localized Prostate Cancer – Dan Spratt
March 4, 2022
Details
AI-derived Digital Pathology-Based Biomarkers in Localized Prostate Cancer - Felix Feng
March 1, 2022
Details
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer – Kara Maxwell
February 4, 2022
Details
NCCN Guidelines 2022 - Prostate Cancer on Comparison of Treatment Options for Localized Disease + Local Therapies + Disease Monitoring - Zachary Klaassen and Chris Wallis
January 17, 2022
Details
Treatment-Related Regret Among Men With Localized Prostate Cancer Journal Club - Christopher Wallis & Zachary Klaassen
December 16, 2021
Details
High Risk Prostate Cancer and Genomics - Paul Nguyen & Alan Pollack
November 18, 2021
Details
NCCN Prostate Cancer Clinical Practice Guidelines on Risk Stratification for Clinically Localized Prostate Cancer – Christopher Wallis & Zachary Klaassen
November 10, 2021
Details
Improving the Quality of Care for Men in Michigan With Prostate Cancer, the MUSIC Collaborative, a Focus on the G-MINOR and G-MAJOR Trials – Todd Morgan
August 30, 2021
Details
Personalized Hormone Therapy with Post-Operative Radiation Therapy and Validation of the Decipher Genomic Classifier in SAKK 09/10 Trial - Dan Spratt and Alan Dal Pra
August 18, 2021
Details
When to Add ADT to Early or Late Salvage Radiation - Dan Spratt
August 18, 2021
Details
Clinical Case Discussions - "Rising PSA 18 Months Post RP and Timing of Radiotherapy" - Ashley Ross, Alan Dal Pra, and Dan Spratt
August 18, 2021
Details
Prostate Cancer Screening and Shared Decision Making in the Veterans Health Administration - Stacy Loeb
August 11, 2021
Details
PCORI-Funded Initiative Evidence Gaps To Guide Future Research on the Use of Active Surveillance for Prostate Cancer – M. Minhaj Siddiqu
July 18, 2021
Details
Prostate Cancer Modeling: The CISNET Prostate Group - Ruth Etzioni
May 9, 2021
Details
A Systematic Review of the Decipher® Genomic Classifier in Prostate Cancer - Ashley Ross & Daniel Spratt
February 16, 2021
Details
Prostate Active Surveillance Study (PASS) - Daniel Lin
November 2, 2020
Details
How Can We Accelerate Clinical Trial Accrual in Localized Prostate Cancer? - Brian F. Chapin
November 13, 2020
Details
An Expert Discussion on Gleason 6 (Grade Group 1) Prostate Cancer - Scott Eggener 
October 4, 2020
Details
DASL-HiCAP (ANZUP1801): The Impact of Darolutamide on Standard Therapy for Localized Very High-risk Cancer of the Prostate - Christopher Sweeney
July 28, 2020
Details
The Role of Neoadjuvant Therapy for Patients with Localized Prostate Cancer - Rana R. McKay
June 8, 2020
Details
Active Surveillance for Low-Risk Prostate Cancer - Laurence Klotz and Peter Carroll
March 13, 2020
Details
Study of Baseline PSA Screening of Men (45 years old) - Peter Albers
December 30, 2019
Details
Radiation Therapy Advances and Technology Overview - Daniel Spratt
December 16, 2019
Details
Epidemiologic Outcomes of Prostate Cancer Patients Undergoing Active Surveillance - Sigrid Carlsson
November 11, 2019
Details
Exercise vs. Usual Care Among Men Opting for Active Surveillance for Prostate Cancer - June Chan
January 15, 2020
Details
Increasing Rates of Active Surveillance as the Standard of Care in Men with Low Risk Prostate Cancer- Matthew Cooperberg
November 6, 2019
Details
ProVent Trial for Newly Diagnosed Prostate Cancer - Benjamin Lowentritt
February 7, 2019
Details
Engagement in Long-Term Physical Activity and Lowering the Risk of Advanced Prostate Cancer - Lorelei Mucci
January 29, 2019
Details
Focal Therapy: Ready or Not - Herbert Lepor
December 1, 2018
Details
EXTEND, Phase 2 Trial Evaluating the Safety and Efficacy of Exercise Training in Men with Hormone Naïve Prostate Cancer - Mike Harrison
October 29, 2018
Details
Long-Term Outcomes of Active Surveillance for Prostate Cancer - Interview with Sigrid Carlsson
June 12, 2018
Details
The Men’s Eating and Living (MEAL) Study, Diet Intervention in Men on Active Surveillance for Prostate Cancer - Interview with J. Kellogg Parsons
May 21, 2018
Details
Active Surveillance: Who is the Right Patient? - Matt Cooperberg
April 17, 2018
Details
email news signup